Granules India informs about revised press release

18 Apr 2019 Evaluate

Granules India has informed about revised press release, titled ‘Granules India Limited received US FDA approval for Acetaminophen 650 mg, Extended Release Tablets’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.